CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −486 | $72.66 | $35K | 144,863 |
| 2024-06-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −117 | $73.46 | $9K | 144,746 |
| 2024-06-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −757 | $71.43 | $54K | 145,297 |
| 2024-06-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −327 | $72.55 | $24K | 144,970 |
| 2024-06-03 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −224 | $73.43 | $16K | 144,746 |
| 2024-05-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $2.03 | $30K | 492,847 |
| 2024-05-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,211 | $68.84 | $428K | 486,636 |
| 2024-05-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,789 | $69.84 | $614K | 477,847 |
| 2024-05-23 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 212,327 | ||
| 2024-05-20 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 103,679 |
| 2024-05-20 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −3,544 | $74.40 | $264K | 100,135 |
| 2024-05-20 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −4,456 | $75.46 | $336K | 95,679 |
| 2024-05-20 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 352,827 | ||
| 2024-05-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise 10b5-1 | +1,667 | $21.41 | $36K | 32,264 |
| 2024-05-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −964 | $61.30 | $59K | 31,300 |
| 2024-05-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −559 | $61.95 | $35K | 30,741 |
| 2024-05-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Sale 10b5-1 | −144 | $63.90 | $9K | 30,597 |
| 2024-05-01 | Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | Option exercise · Stock Option (right to buy) 10b5-1 | −1,667 | 186,665 | ||
| 2024-05-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,753 | $61.23 | $107K | 216,709 |
| 2024-05-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,062 | $61.99 | $66K | 215,647 |
Page 28 of 39 · 764 trades